Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
15.27
+0.86 (5.97%)
At close: Jan 21, 2025, 4:00 PM
14.44
-0.83 (-5.44%)
After-hours: Jan 21, 2025, 6:17 PM EST
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ETON stock have an average target of 18.67, with a low estimate of 17 and a high estimate of 21. The average target predicts an increase of 22.27% from the current stock price of 15.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ETON stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +37.52% | Jan 10, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +17.88% | Jan 8, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +11.33% | Jan 6, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 → $15 | Strong Buy | Reiterates | $11 → $15 | -1.77% | Nov 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -27.96% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
38.68M
from 31.64M
Increased by 22.25%
Revenue Next Year
70.20M
from 38.68M
Increased by 81.48%
EPS This Year
-0.14
from -0.04
EPS Next Year
0.43
from -0.14
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 40.1M | 76.3M | 104.8M | |||
Avg | 38.7M | 70.2M | 101.8M | |||
Low | 36.9M | 63.7M | 97.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 26.6% | 97.2% | 49.3% | |||
Avg | 22.2% | 81.5% | 45.0% | |||
Low | 16.8% | 64.7% | 39.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -0.11 | 0.49 | 0.85 | |||
Avg | -0.14 | 0.43 | 0.83 | |||
Low | -0.17 | 0.36 | 0.79 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | 98.5% | |||
Avg | - | - | 92.9% | |||
Low | - | - | 85.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.